Pharmacogenomic discovery of genetically targeted cancer therapies optimized against clinical outcomes
P. Truesdell, J. Chang, D. Coto Villa, Y. Zhao, R. McIlwain, S. Young, S. Hiley, A. W. Craig, T. Babak
The paper identifies pharmacogenomic screening principles that predict clinical efficacy in cancer patients with specific driver mutations.
bioRxiv · Jan 5, 2024Cancer Biology